Jurenovich Michael J DO is categorized under Orthopedic Doctors and Physicians in Greenville, PA and active since 1999.
Jurenovich Michael J DO was established in 1999, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Jurenovich at the company’s single location by writing to 59 West Main St, Greenville, Pennsylvania PA 16125 or by phoning (724) 588-7531. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Jurenovich Michael J DO |
Contact Person: | Michael Jurenovich |
Address: | 59 West Main St, Greenville, Pennsylvania 16125 |
Phone Number: | (724) 588-7531 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Jurenovich Michael J DO was started in 1999 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Jurenovich for inquiries that concern Jurenovich Michael J DO by calling the company number (724) 588-7531, as your correspondence is most welcome. Additionally, the physical location of the single location of Jurenovich Michael J DO can be found at the coordinates 41.40244,-80.39578 as well as the street address 59 West Main St in Greenville, Pennsylvania 16125.
For its online presence, you may visit Jurenovich Michael J DO’s website at and engage with its social media outlets through on Twitter and on Facebook.